将接受环孢素（山地明）治疗的肾移植患者转换为使用新的微乳剂配方产品，即新山地明。 - Suppr | 超能文献

Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral.

作者信息

Chu S H, Pang S T, Chiang Y J, Chuang C K, Chen H W, Chen C S, Chou C C, Huang C C

机构信息

Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taipei, Taiwan.

出版信息

Transplant Proc. 1998 Nov;30(7):3521-3. doi: 10.1016/s0041-1345(98)01121-x.

DOI:10.1016/s0041-1345(98)01121-x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral.将接受环孢素（山地明）治疗的肾移植患者转换为使用新的微乳剂配方产品，即新山地明。

Transplant Proc. 1998 Nov;30(7):3521-3. doi: 10.1016/s0041-1345(98)01121-x.

2

Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.肾移植患者中，环孢素微乳剂与传统环孢素安全性及耐受性的随机、双盲、为期一年的研究。国际山地明新山地明研究组

Transplantation. 1998 Jun 15;65(11):1455-60. doi: 10.1097/00007890-199806150-00008.

3

Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.环孢素微乳剂（新山地明）在稳定期肾移植患者治疗24个月后的安全性和耐受性。德国新山地明研究组

Transplant Proc. 1996 Aug;28(4):2204-6.

4

Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.

Transplant Proc. 1997 Feb-Mar;29(1-2):303. doi: 10.1016/s0041-1345(96)00118-2.

5

Long-term results of conversion from existing to microemulsion formulation of cyclosporine.环孢素从现有制剂转换为微乳剂制剂的长期结果。

Transplant Proc. 1996 Aug;28(4):2207-13.

6

An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients.一项开放性随机平行组研究，比较山地明新山地明与山地明软胶囊在稳定期肾移植患者中的疗效。

Transplant Proc. 1996 Jun;28(3):1202-3.

7

Conversion from Sandimmune to Neoral in renal transplant recipients: two-year experience.肾移植受者从山地明转换为新山地明：两年经验

Transplant Proc. 1998 Aug;30(5):1753-5. doi: 10.1016/s0041-1345(98)00416-3.

8

Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral.稳定肾移植受者从山地明转换为新山地明后的环孢素药代动力学特征

Transplant Proc. 1996 Jun;28(3):1324-6.

9

Cyclosporine Neoral in renal transplant recipients: impact on hepatic dysfunction.新山地明（环孢素软胶囊）对肾移植受者的影响：对肝功能障碍的作用

Transplant Proc. 1997 Nov;29(7):2939-40. doi: 10.1016/s0041-1345(97)00737-9.

10

Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.

Transplant Proc. 1998 Dec;30(8):3955-7. doi: 10.1016/s0041-1345(98)01303-7.

引用本文的文献

1

Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.环孢素：基于微乳剂的制剂（新山地明）在器官移植中药物动力学特性、临床疗效及耐受性的最新综述

Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.